The 14 most recent market catalysts affecting $CGNX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 23, 2026
Corporate Catalyst
Bearish
Impact 55
Baird Maintains Neutral on Cognex, Lowers Price Target to $70
Baird analyst Richard Eastman reiterated a 'Neutral' rating on Cognex but reduced the price target from $78 to $70. This adjustment signals a slightly less optimistic valuation out…
Sep 22, 2026
Corporate Catalyst
Neutral
Impact 85
Cognex Buys Intel-Spun RealSense For $500 Million
Cognex announced its agreement to acquire RealSense, a developer of depth-sensing cameras and 3D vision technology, for $500 million. This acquisition is a significant strategic mo…
Sep 22, 2026
Corporate Catalyst
Neutral
Impact 65
Cognex Expects To Grant Restricted Stock Units Valued At ~$50M Under Its Existing 2023 Stock Option And Incentive Plan Dependent On Grant-Date Share Price
Cognex is acquiring RealSense for $500 million, funded by existing cash. A key component of this acquisition is a three-year, $56.5 million cash retention program for RealSense emp…
Sep 22, 2026
Corporate Catalyst
Bullish
Impact 92
Cognex Agrees To Acquire RealSense For ~$500M
Cognex Corporation is acquiring RealSense, a leader in 3D robotic perception, for approximately $500 million. This strategic move is significant because it allows Cognex to enter t…
Sep 15, 2026
Corporate Catalyst
Neutral
Impact 55
Needham Reiterates Buy on Cognex, Maintains $80 Price Target
This 8-K filing discloses that Needham analyst Robert Jamieson has reiterated a 'Buy' rating for Cognex (CGNX) and maintained an $80 price target. This action signifies that the an…
Aug 14, 2026
Corporate Catalyst
Bearish
Impact 65
Tiger Global Management Decreases Stake In Cognex Corp By 30% To 339,000 Shares
Tiger Global's 30% stake reduction in Cognex Corp is a notable institutional move, indicating a potential loss of conviction in the company's near-term prospects or a strategic por…
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Cognex, Raises Price Target to $80
Barclays analyst Guy Hardwick has maintained an 'Overweight' rating on Cognex and raised the price target from $75 to $80. This action signals a continued positive sentiment from a…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Needham Maintains Buy on Cognex, Raises Price Target to $80
Needham analyst James Ricchiuti maintained a 'Buy' rating on Cognex (CGNX) and raised the price target from $75 to $80. This action signals continued confidence in the company's pe…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 55
Cantor Fitzgerald Maintains Overweight on Cognex, Raises Price Target to $84
Cantor Fitzgerald analyst Troy Jensen has maintained an 'Overweight' rating on Cognex and raised the price target from $76 to $84. This action signals a continued bullish sentiment…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 85
Cognex shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and issued Q3 guidance above estimates. Also, the company issued FY26 guidance above estimates.
This headline is a significant positive catalyst for Cognex (CGNX). The better-than-expected Q2 adjusted EPS and, more importantly, the Q3 and FY26 guidance exceeding estimates, si…
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 85
Cognex Sees FY2026 Adj EPS $1.64-$1.68 vs $1.49 Est; Sees Sales $1.130B-$1.150B vs $1.111B Est
Cognex's 8-K filing reveals robust financial projections for fiscal year 2026, with adjusted EPS guidance of $1.64-$1.68 significantly higher than the $1.49 analyst estimate, and s…
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 95
Cognex Sees Q3 Adj EPS $0.50-$0.54 vs $0.37 Est; Sees Sales $300.000M-$320.000M vs $280.146M Est
Cognex (CGNX) has released preliminary Q3 guidance indicating adjusted EPS of $0.50-$0.54 and sales of $300M-$320M. These figures are substantially higher than the current analyst …
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 75
Cognex Q2 Adj. EPS $0.45 Beats $0.42 Estimate, Sales $291.263M Miss $292.545M Estimate
Cognex's Q2 earnings present a mixed picture for investors. The significant beat in adjusted EPS, coupled with strong year-over-year growth, indicates effective cost management or …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.